申请人:——
公开号:US05811442A1
公开(公告)日:1998-09-22
Patients suffering from or susceptible to conditions of the vascular or circulatory system, particularly the microvasculature, which conditions are associated with decreased blood flow in regions of microcirculation (e.g., Raynaud's disease and Raynaud's phenomenon) are treated with pharmaceutical compositions incorporating an effective amount of an aryl substituted olefinic amine compound. The compounds incorporated into the pharmaceutical compositions of the present invention exhibit selective activity of to the .beta.2-containing nicotinic acetylcholine receptors and thereby yield beneficial therapeutic effects increasing vascular blood flow in regions of microcirculation.
患有或易感受到血管或循环系统疾病,特别是微血管系统疾病(例如雷诺氏病和雷诺氏现象)的患者,可以使用含有效量芳基取代烯丙胺化合物的制药组合物进行治疗。本发明所述的化合物在制药组合物中表现出对含有β2-乙酰胆碱受体的选择性活性,从而产生有益的治疗效果,增加微循环区域的血液流量。